Differences across counties in the registered prevalence of autism, ADHD, epilepsy and cerebral palsy in Norway
Insights
Prevalence of autism spectrum disorders (ASD) and ADHD in Norwegian children varied significantly by county, likely due to diagnostic practices. Treatment is spread across many institutions, raising questions about appropriateness.
Area of Science:
- Pediatrics
- Child Neurology
- Public Health
Background:
- Previous research in 2012 established the unknown prevalence of childhood developmental disorders and neurological diseases in Norway.
- This study aims to compare diagnostic and treatment practices for these conditions across different Norwegian counties and institutions.
Purpose of the Study:
- To estimate the prevalence of autism spectrum disorders (ASD), ADHD, epilepsy, and cerebral palsy in children aged 0-12 years in Norway.
- To compare the diagnostics and treatment of these conditions across counties and healthcare institutions.
- To investigate potential reasons for variations in prevalence rates.
Main Methods:
- Utilized data from the Norwegian Patient Register for the years 2008-2011.
- Estimated prevalence rates for ASD, ADHD, epilepsy, and cerebral palsy in children aged 0-12.
- Analyzed diagnostic and treatment distribution across 29 somatic hospitals and 102 child and youth psychiatry units.
Main Results:
- Nationwide prevalence in 6-12 year olds: ASD 0.6%, ADHD 2.0%, epilepsy 0.9%, cerebral palsy 0.3%.
- Total prevalence of these diagnoses in twelve-year-olds was 5.0%.
- Significant county-level variation observed for ASD (0.3%-1.5%) and ADHD (1.1%-3.5%), with minimal variation for epilepsy and cerebral palsy.
Conclusions:
- Variations in ASD and ADHD prevalence across counties are likely attributable to differing diagnostic practices.
- The study questions the appropriateness of distributing treatment for these conditions across a large number of institutions.
Background:
In 2012, we published an overview of the prevalence of developmental disorders and neurological diseases in children in Norway, which was unknown at the time. In this article we will compare diagnostics and treatment across counties and institutions.
Material And Method:
The prevalence across counties of autism spectrum disorders, ADHD, epilepsy and cerebral palsy in children aged 0-12 was estimated with the aid of data from the Norwegian Patient Register for the years 2008-11.
Results:
In the age group 6-12 years, nationwide prevalence amounted to 0.6% for autism spectrum disorders, 2.0% for ADHD, 0.9% for epilepsy and 0.3% for cerebral palsy. In total, 5.0% of all twelve-year-olds were registered with one or more of these diagnoses. The prevalence of autism spectrum disorders and ADHD varied between the counties, from 0.3% to 1.5% for autism spectrum disorders and from 1.1% to 3.5% for ADHD. For epilepsy and cerebral palsy there was little variation between the counties. Diagnostics and treatment of these four conditions are spread over 29 somatic hospitals and 102 units for child and youth psychiatry.
Interpretation:
The variations across counties in the prevalence of autism spectrum disorders and ADHD are most likely due to variations in diagnostic practices. We ask whether it is appropriate to spread the provision of treatment across such a high number of institutions.
More Related Videos
08:17A Semantic Priming Event-related Potential (ERP) Task to Study Lexico-semantic and Visuo-semantic Processing in Autism Spectrum Disorder
Published on: April 12, 2018
05:44Concurrent Collection of Fetal Murine Brain and Serum to Assess Effects of Maternal Diet on Nutrition and Neurodevelopment in Neurofibromatosis Type 1
Published on: May 17, 2024
Related Concept Videos
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Epilepsy ll: Types
